수의용 분자진단 시장 보고서(2026년)

Veterinary molecular diagnostics involves the use of molecular biology techniques to identify and diagnose animal diseases at the genetic or molecular level. These diagnostics detect specific pathogens (such as bacteria, viruses, or parasites), genetic mutations, or biomarkers that signal disease, assisting veterinarians in making precise diagnoses and treatment plans.

The main products in veterinary molecular diagnostics include kits, reagents, and instruments. Kits and reagents are crucial for conducting various diagnostic tests on animal samples in laboratories and industrial settings, providing accurate and reliable results necessary for effective treatment and management of diseases. These diagnostics are applicable to both companion animals and livestock, addressing conditions such as infectious and genetic diseases. The primary users of these products are diagnostic laboratories, veterinary clinics, veterinary hospitals, and similar facilities.

Tariffs have impacted the veterinary molecular diagnostics market by increasing the cost of imported kits, reagents, and advanced instruments such as PCR machines and DNA sequencers, affecting pricing and accessibility for diagnostic laboratories and veterinary clinics. Segments like kits and reagents and instruments are most affected, particularly in regions such as North America and Europe reliant on imports. However, tariffs have also stimulated local manufacturing, encouraged development of cost-effective diagnostic solutions, and fostered regional innovation in molecular veterinary diagnostics.

The veterinary molecular diagnostics market research report is one of a series of new reports from The Business Research Company that provides veterinary molecular diagnostics market statistics, including veterinary molecular diagnostics industry global market size, regional shares, competitors with a veterinary molecular diagnostics market share, detailed veterinary molecular diagnostics market segments, market trends and opportunities, and any further data you may need to thrive in the veterinary molecular diagnostics industry. This veterinary molecular diagnostics market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The veterinary molecular diagnostics market size has grown strongly in recent years. It will grow from $0.7 billion in 2025 to $0.77 billion in 2026 at a compound annual growth rate (CAGR) of 9.9%. The growth in the historic period can be attributed to increasing prevalence of infectious and genetic animal diseases, technological advancements in molecular biology, growth of companion and livestock animal populations, rising veterinary awareness and training, adoption of conventional molecular diagnostic kits.

The veterinary molecular diagnostics market size is expected to see strong growth in the next few years. It will grow to $1.11 billion in 2030 at a compound annual growth rate (CAGR) of 9.6%. The growth in the forecast period can be attributed to rising demand for rapid and accurate molecular diagnostics, adoption of ngs and high-throughput platforms, expansion of veterinary genomics services, integration of ai-driven diagnostic analysis, growing emphasis on preventive veterinary care through molecular testing. Major trends in the forecast period include expansion of pcr and rt-pcr-based diagnostics, growing adoption of next-generation sequencing (ngs) in veterinary medicine, development of multiplex diagnostic kits for infectious diseases, integration of molecular diagnostics in routine veterinary care, automation and high-throughput molecular testing solutions.

The high prevalence of zoonotic diseases is expected to drive the growth of the veterinary molecular diagnostics market going forward. Zoonotic diseases are infectious conditions transmitted between animals and humans, caused by bacteria, viruses, parasites, or fungi. Common examples include rabies, Lyme disease, salmonellosis, toxoplasmosis, and more. The prevalence of these diseases is influenced by factors such as deforestation, wildlife exploitation, intensive animal farming, biodiversity loss, and human mobility. Veterinary molecular diagnostics enable early detection of zoonotic diseases in animals, preventing transmission to humans and improving disease management through rapid and accurate pathogen identification. For example, in December 2025, according to the European Centre for Disease Prevention and Control (ECDC), a Sweden-based government agency, the number of reported human cases of key zoonotic diseases in 2024-such as campylobacteriosis (168,396 cases) and salmonellosis (79,703 cases)-continued to rise, highlighting the ongoing prevalence of zoonoses in Europe. Therefore, the high prevalence of zoonotic diseases is driving the veterinary molecular diagnostics market.

Leading players in the veterinary molecular diagnostics market are focusing on automation and scalability in diagnostic technologies, such as high-volume testing machines, to enhance diagnostic accuracy, increase testing efficiency, and enable faster disease detection in animals. High-volume testing machines are advanced diagnostic devices capable of processing large numbers of samples efficiently, supporting rapid and accurate analysis in laboratory or clinical settings, especially for large-scale testing. For instance, in June 2023, Iowa State University's Veterinary Diagnostic Laboratory (VDL), a US-based university, introduced SmartChip, a molecular diagnostic device utilizing quantitative polymerase chain reaction (qPCR) technology. This device can accommodate over 5,000 samples on a plate no larger than a postage stamp, and its capacity increases further when paired with a 384-sample system featuring automated handling. SmartChip employs microfluidic technology, using a sample volume 100 times smaller than standard 96-well machines, to identify targets of interest efficiently.

In April 2023, Mars Incorporated, a US-based diversified manufacturing and petcare company, acquired Heska Corporation for approximately $1.3 billion. Through this acquisition, Mars aimed to strengthen and expand its petcare science and diagnostics capabilities by broadening its veterinary diagnostic offerings and accelerating innovation in point-of-care solutions for the global pet healthcare market. Heska Corporation is a US-based healthcare technology company specializing in the development, manufacture, marketing, and support of advanced veterinary diagnostic and specialty products for veterinary practitioners worldwide.

Major companies operating in the veterinary molecular diagnostics market are Roche Diagnostics Corporation, Thermo Fisher Scientific Inc., Merck KGaA, Zoetis Inc., Illumina Inc., PerkinElmer Inc., bioMerieux S.A., IDEXX Laboratories Inc., Bio-Rad Laboratories Inc., QIAGEN N.V., LGC Group Ltd., Neogen Corporation, Abcam plc, Eiken Chemical Co. Ltd., Bioneer Corporation, INDICAL BIOSCIENCE GmbH, Biochek B.V., Ring Biotechnology Co. Ltd., Ingenetix GmbH, MiDOG Animal Diagnostics LLC, Biolab S.r.l., Bionote USA Inc.

North America was the largest region in the Veterinary Molecular Diagnostics market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the veterinary molecular diagnostics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the veterinary molecular diagnostics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The veterinary molecular diagnostics market consists of revenues earned by entities by providing services such as diagnostic testing services, surveillance testing, genetic testing, toxicology, and biocompatibility testing. The market value includes the value of related goods sold by the service provider or included within the service offering. The veterinary molecular diagnostics market also includes sales of immunoassay kits, diagnostic software, and next-generation sequencing (NGS) systems. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Veterinary Molecular Diagnostics Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses veterinary molecular diagnostics market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
• Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on end user analysis.
• Benchmark performance against key competitors based on market share, innovation, and brand strength.
• Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
• Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for veterinary molecular diagnostics ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The veterinary molecular diagnostics market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
• The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
• The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
• The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
• The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
• The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
• Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

• Markets Covered:1) By Product: Kits And Reagents; Instruments
• 2) By Animal Type: Companion Animals; Livestock Animals
• 3) By Application: Infectious Diseases; Genetic Diseases; Other Applications
• 4) By End-User: Diagnostic Laboratories; Veterinary Clinics; Veterinary Hospitals; Other End-Users
• Subsegments:
• 1) By Kits And Reagents: Polymerase Chain Reaction (PCR) Kits; Reverse Transcription PCR (RT-PCR) Kits; Real-Time PCR Kits; Nucleic Acid Extraction Kits; Enzyme-Linked Immunosorbent Assay (ELISA) Kits; Hybridization Kits; Reagents For Next-Generation Sequencing (NGS)
• 2) By Instruments: PCR Machines (Thermal Cyclers); Real-Time PCR Machines; Nucleic Acid Analyzers; Gel Electrophoresis Equipment; DNA Sequencers; Automated Liquid Handling Systems; Molecular Imaging Systems
• Companies Mentioned: Roche Diagnostics Corporation; Thermo Fisher Scientific Inc.; Merck KGaA; Zoetis Inc.; Illumina Inc.; PerkinElmer Inc.; bioMerieux S.A.; IDEXX Laboratories Inc.; Bio-Rad Laboratories Inc.; QIAGEN N.V.; LGC Group Ltd.; Neogen Corporation; Abcam plc; Eiken Chemical Co. Ltd.; Bioneer Corporation; INDICAL BIOSCIENCE GmbH; Biochek B.V.; Ring Biotechnology Co. Ltd.; Ingenetix GmbH; MiDOG Animal Diagnostics LLC; Biolab S.r.l.; Bionote USA Inc.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time Series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: Word, PDF or Interactive Report
• + Excel Dashboard
• Added Benefits
• Bi-Annual Data Update
• Customisation
• Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

Table of Contents

1. Executive Summary

• 1.1. Key Market Insights (2020-2035)
• 1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots
• 1.3. Major Factors Driving the Market
• 1.4. Top Three Trends Shaping the Market

2. Veterinary Molecular Diagnostics Market Characteristics

• 2.1. Market Definition & Scope
• 2.2. Market Segmentations
• 2.3. Overview of Key Products and Services
• 2.4. Global Veterinary Molecular Diagnostics Market Attractiveness Scoring And Analysis
  • 2.4.1. Overview of Market Attractiveness Framework
  • 2.4.2. Quantitative Scoring Methodology
  • 2.4.3. Factor-Wise Evaluation
• Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation
• 2.4.4. Market Attractiveness Scoring and Interpretation
• 2.4.5. Strategic Implications and Recommendations

3. Veterinary Molecular Diagnostics Market Supply Chain Analysis

• 3.1. Overview of the Supply Chain and Ecosystem
• 3.2. List Of Key Raw Materials, Resources & Suppliers
• 3.3. List Of Major Distributors and Channel Partners
• 3.4. List Of Major End Users

4. Global Veterinary Molecular Diagnostics Market Trends And Strategies

• 4.1. Key Technologies & Future Trends
  • 4.1.1 Digitalization, Cloud, Big Data & Cybersecurity
  • 4.1.2 Industry 4.0 & Intelligent Manufacturing
  • 4.1.3 Internet Of Things (Iot), Smart Infrastructure & Connected Ecosystems
  • 4.1.4 Biotechnology, Genomics & Precision Medicine
  • 4.1.5 Artificial Intelligence & Autonomous Intelligence
• 4.2. Major Trends
  • 4.2.1 Expansion Of Pcr And Rt-Pcr-Based Diagnostics
  • 4.2.2 Growing Adoption Of Next-Generation Sequencing (Ngs) In Veterinary Medicine
  • 4.2.3 Development Of Multiplex Diagnostic Kits For Infectious Diseases
  • 4.2.4 Integration Of Molecular Diagnostics In Routine Veterinary Care
  • 4.2.5 Automation And High-Throughput Molecular Testing Solutions

5. Veterinary Molecular Diagnostics Market Analysis Of End Use Industries

• 5.1 Diagnostic Laboratories
• 5.2 Veterinary Clinics
• 5.3 Veterinary Hospitals
• 5.4 Research Institutes
• 5.5 Academic And Veterinary Training Centers

6. Veterinary Molecular Diagnostics Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Veterinary Molecular Diagnostics Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

• 7.1. Global Veterinary Molecular Diagnostics PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 7.2. Global Veterinary Molecular Diagnostics Market Size, Comparisons And Growth Rate Analysis
• 7.3. Global Veterinary Molecular Diagnostics Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
• 7.4. Global Veterinary Molecular Diagnostics Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Veterinary Molecular Diagnostics Total Addressable Market (TAM) Analysis for the Market

• 8.1. Definition and Scope of Total Addressable Market (TAM)
• 8.2. Methodology and Assumptions
• 8.3. Global Total Addressable Market (TAM) Estimation
• 8.4. TAM vs. Current Market Size Analysis
• 8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Veterinary Molecular Diagnostics Market Segmentation

• 9.1. Global Veterinary Molecular Diagnostics Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Kits And Reagents, Instruments
• 9.2. Global Veterinary Molecular Diagnostics Market, Segmentation By Animal Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Companion Animals, Livestock Animals
• 9.3. Global Veterinary Molecular Diagnostics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Infectious Diseases, Genetic Diseases, Other Applications
• 9.4. Global Veterinary Molecular Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Diagnostic Laboratories, Veterinary Clinics, Veterinary Hospitals, Other End-Users
• 9.5. Global Veterinary Molecular Diagnostics Market, Sub-Segmentation Of Kits And Reagents, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Polymerase Chain Reaction (PCR) Kits, Reverse Transcription PCR (RT-PCR) Kits, Real-Time PCR Kits, Nucleic Acid Extraction Kits, Enzyme-Linked Immunosorbent Assay (ELISA) Kits, Hybridization Kits, Reagents For Next-Generation Sequencing (NGS)
• 9.6. Global Veterinary Molecular Diagnostics Market, Sub-Segmentation Of Instrument, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• PCR Machines (Thermal Cyclers), Real-Time PCR Machines, Nucleic Acid Analyzers, Gel Electrophoresis Equipment, DNA Sequencers, Automated Liquid Handling Systems, Molecular Imaging Systems

10. Veterinary Molecular Diagnostics Market Regional And Country Analysis

• 10.1. Global Veterinary Molecular Diagnostics Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• 10.2. Global Veterinary Molecular Diagnostics Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Veterinary Molecular Diagnostics Market

• 11.1. Asia-Pacific Veterinary Molecular Diagnostics Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 11.2. Asia-Pacific Veterinary Molecular Diagnostics Market, Segmentation By Product, Segmentation By Animal Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Veterinary Molecular Diagnostics Market

• 12.1. China Veterinary Molecular Diagnostics Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 12.2. China Veterinary Molecular Diagnostics Market, Segmentation By Product, Segmentation By Animal Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Veterinary Molecular Diagnostics Market

• 13.1. India Veterinary Molecular Diagnostics Market, Segmentation By Product, Segmentation By Animal Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Veterinary Molecular Diagnostics Market

• 14.1. Japan Veterinary Molecular Diagnostics Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 14.2. Japan Veterinary Molecular Diagnostics Market, Segmentation By Product, Segmentation By Animal Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Veterinary Molecular Diagnostics Market

• 15.1. Australia Veterinary Molecular Diagnostics Market, Segmentation By Product, Segmentation By Animal Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Veterinary Molecular Diagnostics Market

• 16.1. Indonesia Veterinary Molecular Diagnostics Market, Segmentation By Product, Segmentation By Animal Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Veterinary Molecular Diagnostics Market

• 17.1. South Korea Veterinary Molecular Diagnostics Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 17.2. South Korea Veterinary Molecular Diagnostics Market, Segmentation By Product, Segmentation By Animal Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Veterinary Molecular Diagnostics Market

• 18.1. Taiwan Veterinary Molecular Diagnostics Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 18.2. Taiwan Veterinary Molecular Diagnostics Market, Segmentation By Product, Segmentation By Animal Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Veterinary Molecular Diagnostics Market

• 19.1. South East Asia Veterinary Molecular Diagnostics Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 19.2. South East Asia Veterinary Molecular Diagnostics Market, Segmentation By Product, Segmentation By Animal Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Veterinary Molecular Diagnostics Market

• 20.1. Western Europe Veterinary Molecular Diagnostics Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 20.2. Western Europe Veterinary Molecular Diagnostics Market, Segmentation By Product, Segmentation By Animal Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Veterinary Molecular Diagnostics Market

• 21.1. UK Veterinary Molecular Diagnostics Market, Segmentation By Product, Segmentation By Animal Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Veterinary Molecular Diagnostics Market

• 22.1. Germany Veterinary Molecular Diagnostics Market, Segmentation By Product, Segmentation By Animal Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Veterinary Molecular Diagnostics Market

• 23.1. France Veterinary Molecular Diagnostics Market, Segmentation By Product, Segmentation By Animal Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Veterinary Molecular Diagnostics Market

• 24.1. Italy Veterinary Molecular Diagnostics Market, Segmentation By Product, Segmentation By Animal Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Veterinary Molecular Diagnostics Market

• 25.1. Spain Veterinary Molecular Diagnostics Market, Segmentation By Product, Segmentation By Animal Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Veterinary Molecular Diagnostics Market

• 26.1. Eastern Europe Veterinary Molecular Diagnostics Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 26.2. Eastern Europe Veterinary Molecular Diagnostics Market, Segmentation By Product, Segmentation By Animal Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Veterinary Molecular Diagnostics Market

• 27.1. Russia Veterinary Molecular Diagnostics Market, Segmentation By Product, Segmentation By Animal Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Veterinary Molecular Diagnostics Market

• 28.1. North America Veterinary Molecular Diagnostics Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 28.2. North America Veterinary Molecular Diagnostics Market, Segmentation By Product, Segmentation By Animal Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Veterinary Molecular Diagnostics Market

• 29.1. USA Veterinary Molecular Diagnostics Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 29.2. USA Veterinary Molecular Diagnostics Market, Segmentation By Product, Segmentation By Animal Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Veterinary Molecular Diagnostics Market

• 30.1. Canada Veterinary Molecular Diagnostics Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 30.2. Canada Veterinary Molecular Diagnostics Market, Segmentation By Product, Segmentation By Animal Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Veterinary Molecular Diagnostics Market

• 31.1. South America Veterinary Molecular Diagnostics Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 31.2. South America Veterinary Molecular Diagnostics Market, Segmentation By Product, Segmentation By Animal Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Veterinary Molecular Diagnostics Market

• 32.1. Brazil Veterinary Molecular Diagnostics Market, Segmentation By Product, Segmentation By Animal Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Veterinary Molecular Diagnostics Market

• 33.1. Middle East Veterinary Molecular Diagnostics Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 33.2. Middle East Veterinary Molecular Diagnostics Market, Segmentation By Product, Segmentation By Animal Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Veterinary Molecular Diagnostics Market

• 34.1. Africa Veterinary Molecular Diagnostics Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 34.2. Africa Veterinary Molecular Diagnostics Market, Segmentation By Product, Segmentation By Animal Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Veterinary Molecular Diagnostics Market Regulatory and Investment Landscape

36. Veterinary Molecular Diagnostics Market Competitive Landscape And Company Profiles

• 36.1. Veterinary Molecular Diagnostics Market Competitive Landscape And Market Share 2024
  • 36.1.1. Top 10 Companies (Ranked by revenue/share)
• 36.2. Veterinary Molecular Diagnostics Market - Company Scoring Matrix
  • 36.2.1. Market Revenues
  • 36.2.2. Product Innovation Score
  • 36.2.3. Brand Recognition
• 36.3. Veterinary Molecular Diagnostics Market Company Profiles
  • 36.3.1. Roche Diagnostics Corporation Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.2. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.3. Merck KGaA Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.4. Zoetis Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.5. Illumina Inc. Overview, Products and Services, Strategy and Financial Analysis

37. Veterinary Molecular Diagnostics Market Other Major And Innovative Companies

• PerkinElmer Inc., bioMerieux S.A., IDEXX Laboratories Inc., Bio-Rad Laboratories Inc., QIAGEN N.V., LGC Group Ltd., Neogen Corporation, Abcam plc, Eiken Chemical Co. Ltd., Bioneer Corporation, INDICAL BIOSCIENCE GmbH, Biochek B.V., Ring Biotechnology Co. Ltd., Ingenetix GmbH, MiDOG Animal Diagnostics LLC

38. Global Veterinary Molecular Diagnostics Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Veterinary Molecular Diagnostics Market

40. Veterinary Molecular Diagnostics Market High Potential Countries, Segments and Strategies

• 40.1 Veterinary Molecular Diagnostics Market In 2030 - Countries Offering Most New Opportunities
• 40.2 Veterinary Molecular Diagnostics Market In 2030 - Segments Offering Most New Opportunities
• 40.3 Veterinary Molecular Diagnostics Market In 2030 - Growth Strategies
  • 40.3.1 Market Trend Based Strategies
  • 40.3.2 Competitor Strategies

41. Appendix

• 41.1. Abbreviations
• 41.2. Currencies
• 41.3. Historic And Forecast Inflation Rates
• 41.4. Research Inquiries
• 41.5. The Business Research Company
• 41.6. Copyright And Disclaimer